These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2805602)

  • 1. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG; Barnes PJ; Evans TW
    Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
    Kempfert C; Brandt R; Siewert B; Kanowski U; Oddoy A
    Pneumologie; 1991 Oct; 45(10):799-803. PubMed ID: 1758848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG; Barnes PJ; Evans TW
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Ono S; Westcott JY; Voelkel NF
    J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor antagonists increase vascular reactivity in perfused rat lungs.
    Haynes J; Chang SW; Morris KG; Voelkel NF
    J Appl Physiol (1985); 1988 Nov; 65(5):1921-8. PubMed ID: 3209541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor.
    McCormack DG; Crawley DE; Barnes PJ; Evans TW
    Clin Sci (Lond); 1992 Mar; 82(3):259-64. PubMed ID: 1372199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
    Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
    Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor.
    Chang SW; Ohara N; Kuo G; Voelkel NF
    Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study.
    Kecskeméti V; Balogh I
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):723-35. PubMed ID: 11192945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial and vascular effects of Paf in the rat isolated lung are completely blocked by WEB 2086, a novel specific Paf antagonist.
    Casals-Stenzel J; Franke J; Friedrich T; Lichey J
    Br J Pharmacol; 1987 Aug; 91(4):799-802. PubMed ID: 3664079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction.
    Chen CR; Voelkel NF; Chang SW
    J Appl Physiol (1985); 1990 Mar; 68(3):1059-68. PubMed ID: 2341334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
    De Kimpe SJ; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of platelet-activating factor (PAF-acether) to induce decidualization in mice and failure of antagonists of PAF to inhibit implantation.
    Milligan SR; Finn CA
    J Reprod Fertil; 1990 Jan; 88(1):105-12. PubMed ID: 2313629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent effects of platelet-activating factor in the coronary circulation.
    Sagach VF; Zhukova AV; Braquet P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S85-9. PubMed ID: 1282996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterolobin induces rat paw oedema independently of PAF-acether.
    Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
    Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.